Company Active LTD

Company profile

Nanopharm Limited

Your Respiratory Drug Delivery Specialists - Nanopharm Ltd

Nanopharm provide unique technologies and formulation development tools enabling pre-clinical development through to clinical manufacture of OINDPs.

CRN
04371441
Founded
2002
Age
24

Overview

Legal name
NANOPHARM LIMITED
Region
Yorkshire and the Humber
Registered address
5 BRUNTCLIFFE AVENUE
MORLEY
LEEDS
ENGLAND
LS27 0LL
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Nanopharm Limited
CRN 04371441
2
Direct and ultimate controller Active LTD

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

16 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

29 Sep
2024

Accounts With Accounts Type Full

Accounts Analysed

AA | Transaction MzQzNzY0Njc2NWFkaXF6a2N4

Published 29 Sep 2024 01:38

11 Feb
2002

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2024
Funded years
2024
Age at first award
22 years

Projects

2024 Collaborative R&D

Delivery of a Flexible, Agile and Sustainable Supply Chain for the Development of a Generic Triple Dry Powder Inhaler Formulation

1 Jul 2024 to 31 Mar 2026

Awarded
£22,270
Total cost £44,539

The annual economic burden of asthma and chronic obstructive pulmonary disease (COPD) on the NHS in the UK is in the order of £4.9 billion. A National Institute of Health and Care Excellence (NICE) statement suggests that two thirds of asthma deaths would be preventable with better access to basic care and the right treatment. Latest guidelines for treatm...

Product types

Collaborative R&D